Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular angiogenesis.

M Klagsbrun1, M A Moses

  • 1Department of Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. klagsbrun@a1.tch.harvard.edu.

Chemistry & Biology
|July 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines.

Nano letters·2018
Same author

Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy.

Oncogene·2015
Same author

Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.

British journal of cancer·2014
Same author

Increased levels of basic fibroblast growth factor (bFGF) following focal brain injury.

Restorative neurology and neuroscience·2011
Same author

Smooth muscle cell and endothelial cell growth factors.

Trends in cardiovascular medicine·2011
Same author

Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine.

British journal of cancer·2008
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
Same journal

Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation.

Chemistry & biology·2015
See all related articles

New research identifies factors controlling blood vessel growth (angiogenesis). These discoveries are paving the way for new therapies targeting ischemic diseases and tumor growth by either stimulating or inhibiting blood vessel formation.

Area of Science:

  • Biomedical research
  • Vascular biology
  • Molecular medicine

Background:

  • Blood vessel development, or angiogenesis, is a complex biological process.
  • Understanding the molecular mechanisms of angiogenesis is crucial for treating various diseases.
  • Recent advancements have identified key regulatory factors involved in this process.

Purpose of the Study:

  • To summarize recent insights into the mechanisms of angiogenesis.
  • To highlight the therapeutic applications of angiogenesis-stimulating and inhibiting factors.
  • To provide an overview of current strategies in vascular biology research.

Main Methods:

  • Literature review of recent studies on angiogenesis.
  • Analysis of identified angiogenesis-stimulating factors.

Related Experiment Videos

  • Analysis of identified anti-angiogenesis factors.

    • Main Results:

    • Identification of specific factors that promote angiogenesis.
    • Identification of specific factors that inhibit angiogenesis.
    • Demonstration of therapeutic potential for both types of factors.

    Conclusions:

    • Targeting angiogenesis holds significant therapeutic promise.
    • Angiogenesis-stimulating factors are beneficial for treating ischemic diseases.
    • Anti-angiogenesis factors are effective in controlling tumor growth and metastasis.